Share Price and Basic Stock Data
Last Updated: December 16, 2025, 4:12 am
| PEG Ratio | 0.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Forbes & Company Ltd operates in the engineering sector, with a focus on general engineering services. The company’s stock price currently stands at ₹320, reflecting a market capitalization of ₹413 Cr. Over the past few quarters, the revenue trajectory has shown significant fluctuations. For instance, sales plummeted to ₹11.26 Cr in March 2023, but have since rebounded to ₹15.54 Cr in September 2023, and ₹87.08 Cr in March 2024. However, this recovery does not erase the memory of a dramatic decline in revenues, which fell from ₹3,067 Cr in FY 2014 to just ₹47 Cr in FY 2023, indicating a turbulent operational history. Despite these challenges, the trailing twelve months (TTM) revenue has stabilized at ₹186 Cr, suggesting a potential recovery phase. The company’s ability to navigate these fluctuations will be critical as it seeks to regain investor trust and market position.
Profitability and Efficiency Metrics
When examining profitability, Forbes & Company has demonstrated a remarkable return on equity (ROE) of 62.4%, signaling an efficient use of shareholder capital. However, the company’s operating profit margin (OPM) has been inconsistent, standing at a low 5.12% in the most recent reporting period, with quarterly OPMs showing volatility; it even dipped to -32.68% in March 2023. This inconsistency highlights operational challenges that need addressing. On the efficiency front, the cash conversion cycle (CCC) stands at a commendable -13 days, indicating that the company is quickly converting its investments into cash flow. This is a strong positive, as it suggests effective management of working capital. However, the erratic nature of both sales and profitability metrics raises questions about the sustainability of this efficiency, particularly in light of fluctuating revenues.
Balance Sheet Strength and Financial Ratios
The balance sheet of Forbes & Company exhibits a solid foundation, particularly with total borrowings at a mere ₹6 Cr, which is notably low compared to its reserves of ₹217 Cr. This translates to a debt-to-equity ratio of effectively zero, indicating a low financial risk and a comfortable position for future investments or to weather potential downturns. The interest coverage ratio (ICR) is an impressive 83.50x, reinforcing the company’s ability to meet its interest obligations with ease. However, the price-to-book value ratio (P/BV) stands at 1.71x, which, while not excessively high, does suggest that the stock may not be undervalued. Investors should consider this in light of the company’s recent performance, which has been marked by significant fluctuations and operational challenges, calling for a nuanced understanding of its financial health.
Shareholding Pattern and Investor Confidence
Forbes & Company has a concentrated shareholding structure, with promoters holding 73.85% of the company, which indicates a strong alignment of interests between management and shareholders. However, foreign institutional investors (FIIs) have reduced their stake to 8.24%, a decline from previous levels, which may reflect concerns over the company’s recent performance volatility. Domestic institutional investors (DIIs) remain marginal, holding only 0.19% of shares. The public stake has slightly increased to 16.87%, suggesting a cautious interest from retail investors. This mixed sentiment in the shareholding pattern may indicate a degree of apprehension among institutional investors, which could impact future share price movements and investor confidence. A more stable performance could entice a broader base of institutional and retail investors back into the fold.
Outlook, Risks, and Final Insight
The outlook for Forbes & Company hinges on its ability to stabilize operations and grow revenues sustainably. The recent recovery in sales is promising, yet the inconsistencies in profitability metrics present a risk that could deter potential investors. Additionally, while the strong balance sheet provides a buffer against financial distress, the company’s historical volatility raises concerns about its operational effectiveness. Investors should be wary of these risks, particularly in a sector that can be sensitive to economic cycles. The potential for growth exists, especially if the management can leverage its low debt levels to invest in operational improvements and innovation. However, the mixed signals from shareholding patterns and profitability metrics suggest that a cautious approach may be warranted. In essence, while opportunities abound, prospective investors should weigh these against the backdrop of past performance and current uncertainties.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 210 Cr. | 617 | 1,086/541 | 16.7 | 218 | 0.49 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 23.6 Cr. | 78.5 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 6.32 Cr. | 14.6 | 16.8/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 8.32 Cr. | 13.5 | 16.0/10.3 | 4.68 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 54.1 Cr. | 0.58 | 6.44/0.48 | 6.51 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,602.82 Cr | 458.15 | 51.46 | 119.01 | 0.29% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 121.85 | 64.42 | 60.75 | 11.26 | 11.37 | 15.54 | 11.89 | 87.08 | 35.79 | 34.66 | 40.23 | 88.68 | 22.45 |
| Expenses | 121.76 | 57.05 | 63.60 | 14.94 | 11.30 | 17.04 | 11.81 | 83.58 | 31.00 | 30.45 | 36.75 | 77.13 | 21.30 |
| Operating Profit | 0.09 | 7.37 | -2.85 | -3.68 | 0.07 | -1.50 | 0.08 | 3.50 | 4.79 | 4.21 | 3.48 | 11.55 | 1.15 |
| OPM % | 0.07% | 11.44% | -4.69% | -32.68% | 0.62% | -9.65% | 0.67% | 4.02% | 13.38% | 12.15% | 8.65% | 13.02% | 5.12% |
| Other Income | 195.02 | 13.64 | 8.15 | 14.10 | 17.40 | -20.24 | 2.96 | -1.03 | 2.31 | 2.60 | 10.19 | 97.29 | 5.34 |
| Interest | 6.51 | 4.12 | 3.51 | -0.90 | 0.24 | 0.39 | 0.17 | 0.80 | 0.23 | 0.20 | 0.21 | 0.13 | 0.16 |
| Depreciation | 6.82 | 4.50 | 4.49 | 1.36 | 0.41 | 0.46 | 0.35 | 0.43 | 0.38 | 0.37 | 0.42 | 0.41 | 0.57 |
| Profit before tax | 181.78 | 12.39 | -2.70 | 9.96 | 16.82 | -22.59 | 2.52 | 1.24 | 6.49 | 6.24 | 13.04 | 108.30 | 5.76 |
| Tax % | 19.87% | -223.00% | 51.11% | -2.71% | 36.09% | 0.53% | -55.95% | -173.39% | 18.64% | 17.63% | 27.15% | 5.04% | 15.62% |
| Net Profit | 145.66 | 40.02 | -4.08 | 10.23 | 10.75 | -22.71 | 3.93 | 3.39 | 5.28 | 5.14 | 9.50 | 102.84 | 4.86 |
| EPS in Rs | 113.01 | 31.02 | -3.16 | 7.93 | 8.33 | -17.60 | 3.05 | 2.63 | 4.09 | 3.98 | 7.36 | 79.72 | 3.77 |
Last Updated: August 19, 2025, 3:29 pm
Below is a detailed analysis of the quarterly data for Forbes & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 22.45 Cr.. The value appears to be declining and may need further review. It has decreased from 88.68 Cr. (Mar 2025) to 22.45 Cr., marking a decrease of 66.23 Cr..
- For Expenses, as of Jun 2025, the value is 21.30 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 77.13 Cr. (Mar 2025) to 21.30 Cr., marking a decrease of 55.83 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.15 Cr.. The value appears to be declining and may need further review. It has decreased from 11.55 Cr. (Mar 2025) to 1.15 Cr., marking a decrease of 10.40 Cr..
- For OPM %, as of Jun 2025, the value is 5.12%. The value appears to be declining and may need further review. It has decreased from 13.02% (Mar 2025) to 5.12%, marking a decrease of 7.90%.
- For Other Income, as of Jun 2025, the value is 5.34 Cr.. The value appears to be declining and may need further review. It has decreased from 97.29 Cr. (Mar 2025) to 5.34 Cr., marking a decrease of 91.95 Cr..
- For Interest, as of Jun 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Mar 2025) to 0.16 Cr., marking an increase of 0.03 Cr..
- For Depreciation, as of Jun 2025, the value is 0.57 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.41 Cr. (Mar 2025) to 0.57 Cr., marking an increase of 0.16 Cr..
- For Profit before tax, as of Jun 2025, the value is 5.76 Cr.. The value appears to be declining and may need further review. It has decreased from 108.30 Cr. (Mar 2025) to 5.76 Cr., marking a decrease of 102.54 Cr..
- For Tax %, as of Jun 2025, the value is 15.62%. The value appears to be increasing, which may not be favorable. It has increased from 5.04% (Mar 2025) to 15.62%, marking an increase of 10.58%.
- For Net Profit, as of Jun 2025, the value is 4.86 Cr.. The value appears to be declining and may need further review. It has decreased from 102.84 Cr. (Mar 2025) to 4.86 Cr., marking a decrease of 97.98 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.77. The value appears to be declining and may need further review. It has decreased from 79.72 (Mar 2025) to 3.77, marking a decrease of 75.95.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:43 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,067 | 3,546 | 3,231 | 2,999 | 2,822 | 2,853 | 2,731 | 932 | 515 | 47 | 125 | 199 | 170 |
| Expenses | 2,914 | 3,417 | 3,194 | 2,892 | 2,693 | 2,710 | 2,701 | 821 | 465 | 76 | 119 | 173 | 151 |
| Operating Profit | 153 | 129 | 37 | 106 | 129 | 143 | 30 | 111 | 49 | -29 | 6 | 26 | 19 |
| OPM % | 5% | 4% | 1% | 4% | 5% | 5% | 1% | 12% | 10% | -63% | 5% | 13% | 11% |
| Other Income | 52 | 65 | 135 | 134 | 39 | 35 | -171 | -48 | 4,252 | 243 | -5 | 110 | 119 |
| Interest | 79 | 91 | 107 | 74 | 96 | 89 | 101 | 52 | 42 | 10 | 1 | 1 | 1 |
| Depreciation | 54 | 22 | 75 | 71 | 77 | 77 | 98 | 68 | 41 | 6 | 2 | 2 | 2 |
| Profit before tax | 72 | 81 | -9 | 95 | -4 | 11 | -341 | -56 | 4,218 | 198 | -2 | 134 | 135 |
| Tax % | 30% | 54% | 423% | 26% | 682% | 126% | -1% | 107% | -0% | 3% | 116% | 8% | |
| Net Profit | 50 | 37 | -48 | 89 | -32 | -3 | -338 | -117 | 4,229 | 192 | -4 | 123 | 124 |
| EPS in Rs | 31.05 | 25.17 | -45.39 | 65.49 | -15.07 | 5.40 | -251.63 | -60.21 | 3,278.84 | 148.80 | -3.46 | 95.16 | 95.76 |
| Dividend Payout % | 0% | 0% | 0% | 4% | -17% | 93% | 0% | 0% | 0% | 44% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.00% | -229.73% | 285.42% | -135.96% | 90.62% | -11166.67% | 65.38% | 3714.53% | -95.46% | -102.08% | 3175.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -203.73% | 515.15% | -421.37% | 226.58% | -11257.29% | 11232.05% | 3649.15% | -3809.99% | -6.62% | 3277.08% |
Forbes & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -25% |
| 5 Years: | -41% |
| 3 Years: | -27% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 23% |
| 3 Years: | -71% |
| TTM: | 76% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 68% |
| 3 Years: | 12% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 14% |
| Last Year: | 62% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: December 4, 2025, 2:53 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 398 | 431 | 206 | 301 | 303 | 251 | -101 | -154 | 73 | 212 | 127 | 207 | 217 |
| Borrowings | 918 | 1,180 | 1,140 | 1,164 | 1,189 | 1,070 | 1,137 | 523 | 288 | 9 | 5 | 5 | 6 |
| Other Liabilities | 1,160 | 1,188 | 1,220 | 1,228 | 1,254 | 1,541 | 1,695 | 1,654 | 415 | 467 | 275 | 77 | 65 |
| Total Liabilities | 2,488 | 2,811 | 2,579 | 2,706 | 2,759 | 2,874 | 2,744 | 2,036 | 789 | 701 | 421 | 301 | 302 |
| Fixed Assets | 878 | 1,140 | 997 | 1,036 | 1,139 | 1,134 | 1,027 | 598 | 158 | 29 | 27 | 27 | 27 |
| CWIP | 29 | 51 | 72 | 74 | 94 | 87 | 29 | 4 | 1 | 0 | 0 | 0 | 0 |
| Investments | 10 | 26 | 92 | 73 | 80 | 81 | 123 | 60 | 117 | 145 | 171 | 200 | 208 |
| Other Assets | 1,571 | 1,594 | 1,418 | 1,524 | 1,445 | 1,573 | 1,565 | 1,374 | 513 | 527 | 223 | 74 | 66 |
| Total Assets | 2,488 | 2,811 | 2,579 | 2,706 | 2,759 | 2,874 | 2,744 | 2,036 | 789 | 701 | 421 | 301 | 302 |
Below is a detailed analysis of the balance sheet data for Forbes & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 217.00 Cr.. The value appears strong and on an upward trend. It has increased from 207.00 Cr. (Mar 2025) to 217.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 5.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 65.00 Cr.. The value appears to be improving (decreasing). It has decreased from 77.00 Cr. (Mar 2025) to 65.00 Cr., marking a decrease of 12.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 302.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 301.00 Cr. (Mar 2025) to 302.00 Cr., marking an increase of 1.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 208.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2025) to 208.00 Cr., marking an increase of 8.00 Cr..
- For Other Assets, as of Sep 2025, the value is 66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 66.00 Cr., marking a decrease of 8.00 Cr..
- For Total Assets, as of Sep 2025, the value is 302.00 Cr.. The value appears strong and on an upward trend. It has increased from 301.00 Cr. (Mar 2025) to 302.00 Cr., marking an increase of 1.00 Cr..
Notably, the Reserves (217.00 Cr.) exceed the Borrowings (6.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -765.00 | 128.00 | 36.00 | 105.00 | 128.00 | 142.00 | 29.00 | -412.00 | -239.00 | -38.00 | 1.00 | 21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 60 | 59 | 56 | 54 | 60 | 54 | 47 | 62 | 61 | 20 | 15 |
| Inventory Days | 131 | 102 | 98 | 138 | 155 | 220 | 284 | 188 | 533 | 892 | 43 | |
| Days Payable | 192 | 162 | 140 | 115 | 142 | 151 | 162 | 99 | 214 | 217 | 71 | |
| Cash Conversion Cycle | 5 | 0 | 17 | 79 | 68 | 128 | 177 | 136 | 380 | 61 | 695 | -13 |
| Working Capital Days | -32 | -17 | -29 | -27 | -42 | -71 | -126 | -273 | -135 | -175 | -299 | -49 |
| ROCE % | 14% | 11% | 3% | 5% | 5% | 7% | -2% | 14% | 12% | -9% | 5% | 16% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 96.42 | -3.50 | 150.77 | 3319.02 | -61.00 |
| Diluted EPS (Rs.) | 96.42 | -3.50 | 150.77 | 3319.02 | -64.00 |
| Cash EPS (Rs.) | 97.73 | -0.53 | 167.51 | 3298.18 | -21.47 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 170.16 | 60.88 | 126.35 | 63.87 | -66.31 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 170.16 | 60.88 | 126.35 | 63.87 | -66.31 |
| Revenue From Operations / Share (Rs.) | 154.46 | 97.60 | 342.65 | 399.06 | 2214.80 |
| PBDIT / Share (Rs.) | 34.16 | 23.06 | 193.00 | 65.03 | 208.82 |
| PBIT / Share (Rs.) | 32.94 | 21.79 | 171.91 | 32.91 | 133.43 |
| PBT / Share (Rs.) | 32.51 | 18.22 | 167.59 | -271.19 | -28.06 |
| Net Profit / Share (Rs.) | 96.51 | -1.81 | 146.42 | 3266.05 | -96.86 |
| NP After MI And SOA / Share (Rs.) | 95.17 | -3.46 | 148.82 | 3276.21 | -60.21 |
| PBDIT Margin (%) | 22.11 | 23.62 | 56.32 | 16.29 | 9.42 |
| PBIT Margin (%) | 21.32 | 22.32 | 50.16 | 8.24 | 6.02 |
| PBT Margin (%) | 21.04 | 18.66 | 48.90 | -67.95 | -1.26 |
| Net Profit Margin (%) | 62.48 | -1.85 | 42.73 | 818.44 | -4.37 |
| NP After MI And SOA Margin (%) | 61.61 | -3.54 | 43.43 | 820.99 | -2.71 |
| Return on Networth / Equity (%) | 55.93 | -5.67 | 117.78 | 5116.97 | 0.00 |
| Return on Capital Employeed (%) | 17.19 | 17.86 | 76.07 | 23.27 | 52.91 |
| Return On Assets (%) | 40.27 | -1.05 | 27.37 | 530.11 | -3.80 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.11 | 0.81 | -1.63 |
| Total Debt / Equity (X) | 0.00 | 0.05 | 0.31 | 3.33 | -4.19 |
| Asset Turnover Ratio (%) | 0.54 | 0.22 | 0.37 | 0.18 | 0.34 |
| Current Ratio (X) | 1.61 | 0.86 | 0.92 | 0.72 | 0.61 |
| Quick Ratio (X) | 1.36 | 0.40 | 0.40 | 0.39 | 0.34 |
| Inventory Turnover Ratio (X) | 2.93 | 0.11 | 0.48 | 0.25 | 0.13 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 43.11 | 96.21 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 37.76 | 95.28 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 56.89 | 3.79 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 62.24 | 4.72 | 0.00 |
| Interest Coverage Ratio (X) | 83.50 | 18.55 | 14.15 | 2.00 | 3.10 |
| Interest Coverage Ratio (Post Tax) (X) | 59.08 | 15.99 | 11.02 | 1.25 | 1.06 |
| Enterprise Value (Cr.) | 348.67 | 527.07 | 739.90 | 782.54 | 2819.46 |
| EV / Net Operating Revenue (X) | 1.75 | 4.19 | 1.67 | 1.52 | 0.98 |
| EV / EBITDA (X) | 7.91 | 17.72 | 2.97 | 9.33 | 10.47 |
| MarketCap / Net Operating Revenue (X) | 1.89 | 4.43 | 1.71 | 1.03 | 0.77 |
| Retention Ratios (%) | 0.00 | 0.00 | 56.88 | 3.78 | 0.00 |
| Price / BV (X) | 1.71 | 7.10 | 4.63 | 6.41 | -14.83 |
| Price / Net Operating Revenue (X) | 1.89 | 4.43 | 1.71 | 1.03 | 0.77 |
| EarningsYield | 0.32 | -0.01 | 0.25 | 7.98 | -0.03 |
After reviewing the key financial ratios for Forbes & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 96.42. This value is within the healthy range. It has increased from -3.50 (Mar 24) to 96.42, marking an increase of 99.92.
- For Diluted EPS (Rs.), as of Mar 25, the value is 96.42. This value is within the healthy range. It has increased from -3.50 (Mar 24) to 96.42, marking an increase of 99.92.
- For Cash EPS (Rs.), as of Mar 25, the value is 97.73. This value is within the healthy range. It has increased from -0.53 (Mar 24) to 97.73, marking an increase of 98.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 170.16. It has increased from 60.88 (Mar 24) to 170.16, marking an increase of 109.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 170.16. It has increased from 60.88 (Mar 24) to 170.16, marking an increase of 109.28.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 154.46. It has increased from 97.60 (Mar 24) to 154.46, marking an increase of 56.86.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 34.16. This value is within the healthy range. It has increased from 23.06 (Mar 24) to 34.16, marking an increase of 11.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is 32.94. This value is within the healthy range. It has increased from 21.79 (Mar 24) to 32.94, marking an increase of 11.15.
- For PBT / Share (Rs.), as of Mar 25, the value is 32.51. This value is within the healthy range. It has increased from 18.22 (Mar 24) to 32.51, marking an increase of 14.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 96.51. This value is within the healthy range. It has increased from -1.81 (Mar 24) to 96.51, marking an increase of 98.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 95.17. This value is within the healthy range. It has increased from -3.46 (Mar 24) to 95.17, marking an increase of 98.63.
- For PBDIT Margin (%), as of Mar 25, the value is 22.11. This value is within the healthy range. It has decreased from 23.62 (Mar 24) to 22.11, marking a decrease of 1.51.
- For PBIT Margin (%), as of Mar 25, the value is 21.32. This value exceeds the healthy maximum of 20. It has decreased from 22.32 (Mar 24) to 21.32, marking a decrease of 1.00.
- For PBT Margin (%), as of Mar 25, the value is 21.04. This value is within the healthy range. It has increased from 18.66 (Mar 24) to 21.04, marking an increase of 2.38.
- For Net Profit Margin (%), as of Mar 25, the value is 62.48. This value exceeds the healthy maximum of 10. It has increased from -1.85 (Mar 24) to 62.48, marking an increase of 64.33.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 61.61. This value exceeds the healthy maximum of 20. It has increased from -3.54 (Mar 24) to 61.61, marking an increase of 65.15.
- For Return on Networth / Equity (%), as of Mar 25, the value is 55.93. This value is within the healthy range. It has increased from -5.67 (Mar 24) to 55.93, marking an increase of 61.60.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 17.86 (Mar 24) to 17.19, marking a decrease of 0.67.
- For Return On Assets (%), as of Mar 25, the value is 40.27. This value is within the healthy range. It has increased from -1.05 (Mar 24) to 40.27, marking an increase of 41.32.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.54. It has increased from 0.22 (Mar 24) to 0.54, marking an increase of 0.32.
- For Current Ratio (X), as of Mar 25, the value is 1.61. This value is within the healthy range. It has increased from 0.86 (Mar 24) to 1.61, marking an increase of 0.75.
- For Quick Ratio (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 0.40 (Mar 24) to 1.36, marking an increase of 0.96.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 4. It has increased from 0.11 (Mar 24) to 2.93, marking an increase of 2.82.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 83.50. This value is within the healthy range. It has increased from 18.55 (Mar 24) to 83.50, marking an increase of 64.95.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 59.08. This value is within the healthy range. It has increased from 15.99 (Mar 24) to 59.08, marking an increase of 43.09.
- For Enterprise Value (Cr.), as of Mar 25, the value is 348.67. It has decreased from 527.07 (Mar 24) to 348.67, marking a decrease of 178.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.75. This value is within the healthy range. It has decreased from 4.19 (Mar 24) to 1.75, marking a decrease of 2.44.
- For EV / EBITDA (X), as of Mar 25, the value is 7.91. This value is within the healthy range. It has decreased from 17.72 (Mar 24) to 7.91, marking a decrease of 9.81.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 4.43 (Mar 24) to 1.89, marking a decrease of 2.54.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has decreased from 7.10 (Mar 24) to 1.71, marking a decrease of 5.39.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 4.43 (Mar 24) to 1.89, marking a decrease of 2.54.
- For EarningsYield, as of Mar 25, the value is 0.32. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.32, marking an increase of 0.33.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Forbes & Company Ltd:
- Net Profit Margin: 62.48%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.19% (Industry Average ROCE: 35.65%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 55.93% (Industry Average ROE: 14.37%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 59.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.36
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.7 (Industry average Stock P/E: 39.07)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 62.48%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | Forbes Building, Mumbai Maharashtra 400001 | investor.relations@forbes.co.in http://www.forbes.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. M C Tahilyani | Chairman & Non-Exe.Director |
| Mr. Nirmal Jagawat | Whole Time Director |
| Mr. Jai L Mavani | Non Executive Director |
| Mr. Nikhil Bhatia | Independent Director |
| Mr. Paras Savla | Independent Director |
| Mr. Bapsy Dastur | Independent Director |
FAQ
What is the intrinsic value of Forbes & Company Ltd?
Forbes & Company Ltd's intrinsic value (as of 16 December 2025) is 1332.33 which is 312.49% higher the current market price of 323.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 417 Cr. market cap, FY2025-2026 high/low of 489/264, reserves of ₹217 Cr, and liabilities of 302 Cr.
What is the Market Cap of Forbes & Company Ltd?
The Market Cap of Forbes & Company Ltd is 417 Cr..
What is the current Stock Price of Forbes & Company Ltd as on 16 December 2025?
The current stock price of Forbes & Company Ltd as on 16 December 2025 is 323.
What is the High / Low of Forbes & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Forbes & Company Ltd stocks is 489/264.
What is the Stock P/E of Forbes & Company Ltd?
The Stock P/E of Forbes & Company Ltd is 14.7.
What is the Book Value of Forbes & Company Ltd?
The Book Value of Forbes & Company Ltd is 178.
What is the Dividend Yield of Forbes & Company Ltd?
The Dividend Yield of Forbes & Company Ltd is 0.00 %.
What is the ROCE of Forbes & Company Ltd?
The ROCE of Forbes & Company Ltd is 15.8 %.
What is the ROE of Forbes & Company Ltd?
The ROE of Forbes & Company Ltd is 62.4 %.
What is the Face Value of Forbes & Company Ltd?
The Face Value of Forbes & Company Ltd is 10.0.